Board of Directors

Alan C. Nelson, PhD – Chairman of the Board

Dr. Nelson, is founder, chairman and CEO of VisionGate®. He is a physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. He is former Executive Director of Arizona State University’s (ASU) Biodesign Institute and has held faculty positions at ASU, University of Washington, MIT and Harvard. Dr. Nelson holds more than 100 US patents and has more than 100 peer-reviewed publications in the field of biomedical imaging.

Walter Robb, PhD – Board Director

Dr. Robb is currently a management consultant and president of Vantage Management, Inc. He serves on the board of Mechanical Technology, Inc., eight private, start-up companies and is a former Celgene board member. He previously served as senior vice president for General Electric’s Corporate Research and Development center, one of the world’s largest and most diversified industrial laboratories, and served on the company’s Corporate Executive Council. Additionally, he headed GE Medical Systems for 13 years.

Maria Forero, MPH – Board Director

Ms. Forero is founder and principal of Ridgetop Health, the life sciences private equity arm of Ridgetop Capital Partners, a $500 million AUM investment firm. Prior to Ridgetop, Maria spent ten years at Novartis in numerous senior management roles across geographies and divisions including Head of Sales & Marketing for Sandoz Latin America and General Manager of Spain & Portugal for Novartis Vaccines. Before Novartis, Ms. Forero was a VP at Morgan Stanley and an Audit Manager at PricewaterhouseCoopers in London. She holds a Masters of Public Health from Columbia University, New York and a BSc in Human Genetics, from the University College London, UK.

James Burns, DLS – Board Director

Dr. Burns has executive experience in the pharmaceutical, biotechnology, medical device, and diagnostic fields ranges from CEO, C-suite executive, company founder, commercialization, finance, and general management. He has worked within businesses from early-stage companies to large multinational corporations, venture capital, and private equity. Most recently, Jim served as Chairman of the Board, Executive Chairman and as President & Chief Executive Officer of Assurex Health, Inc., acquired by Myriad Genetics in 2016. Jim is a Board Leadership Fellow of the U.S. National Association of Corporate Directors (NACD). He earned B.S. and M.S. degrees in Biological Sciences from the University of Illinois, an M.B.A. from DePaul University, and a D.L.S. from Georgetown University.

This website may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and made in reliance on the "safe harbor" provisions of said act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of VisionGate® management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, the acceptance by customers of our products, our ability to develop new products cost-effectively, our ability to raise capital in the future, the development by competitors of products using improved or alternative technology, the retention of key employees and general economic conditions. Forward-looking statements are subject to change without notice.

Contact Us

If you are interested in learning more about VisionGate and would like to speak with someone, please complete this short inquiry form and a representative will contact you as soon as possible.

Copyright 2019 - VisionGate, Inc.